Latest Headlines

1. Waters Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System, Enabling Broader Access To Bloodstream Infection Diagnostics 6/3/2026

   Waters Corporation (NYSE: WAT) today announced that the BD BACTEC FXI Culture System has received U.S. Food and Drug Administration (FDA) 510(k) clearance.

2. Zepto Life Technology Receives FDA Breakthrough Device Designation For Targeted Liquid Biopsy Test For Invasive Mold Infections 6/3/2026

   Zepto Life Technology announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the FungiFlex® Mold Panel, a liquid biopsy test designed to aid in the diagnosis of invasive mold infections through detection and identification of fungal cell-free DNA directly from plasma.

3. SGS Expands Bioanalytical Testing Capabilities In North America With Acquisition Of CMIC, INC. 6/3/2026

   SGS, the world's leading testing, inspection and certification company, is pleased to announce that it has acquired CMIC, INC., a specialized provider of bioanalytical testing services based in Chicago, Illinois (United States).

4. Co-Diagnostics And CoSara Advance Ebola PCR Test Development And Co-Dx™ PCR Point-Of-Care Platform Capabilities 6/2/2026

   Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced continued progress in its Ebola PCR development program with joint venture CoSara Diagnostics Pvt. Ltd. ("CoSara" or the "JV").

5. CirrusDx Now Offers Susceptibility Testing For Blujepa® (gepotidacin), A Recently Approved Antibiotic For Urinary Tract Infections 6/2/2026

   CirrusDx, Inc. (CirrusDx), an infectious disease laboratory and diagnostics company, today announced it now offers antimicrobial susceptibility testing (AST) for gepotidacin (Blujepa®), GSK's recently approved oral antibiotic for uncomplicated urinary tract infections (uUTIs).

6. Collaboration To Improve Sustainable Laboratory Workflows 6/1/2026

   Azenta Life Sciences has announced a collaboration with PulpFixin, a pioneering manufacturer of sustainable labware, to help laboratories reduce plastic waste without sacrificing performance, traceability, or operational efficiency.

7. HNL Lab Medicine Receives Accreditation From The College Of American Pathologists 5/29/2026

   HNL Lab Medicine has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) following a recent on-site inspection conducted by CAP inspectors.

8. Labcorp Supports Multi-Institution Trial To Expand Genetic Testing In Colorectal Cancer 5/29/2026

   Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, multicenter clinical trial for patients newly diagnosed with colorectal cancer (CRC).

9. Leica Biosystems And CellCarta Expand Collaborative Companion Diagnostic Development Model To Accelerate Commercialization Globally 5/29/2026

   CellCarta, a leading global precision medicine laboratory services provider and Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced a strategic partnership to bring a proven companion diagnostic (CDx) joint development model from China to biopharma sponsors globally.

10. DELFI Diagnostics Receives New York State Department Of Health Clinical Laboratory Permit, Completing Authorization To Serve Health Systems Across All 50 States 5/28/2026

    DELFI Diagnostics, Inc., developer of AI-powered, blood-based tests for cancer detection, today announced it has received a Clinical Laboratory Permit and Test Approval letter from the New York State Department of Health (NYSDOH). With this permit, DELFI is now authorized to offer its FirstLook™ Lung laboratory-developed test (LDT) in New York.